Software and AI companies at ACT 2026
Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website
18 software and AI companies are at ACT 2026 — 29 presentations on the program and 9 with a booth in the exhibit hall. Most represented: Human Chemical (3 on the program), Schrödinger (2 on the program), Certara (1 on the program). 13 of them have their own page in this guide. As of Oct 8, 2026.
Topic
Top represented
Showing 1–14 of 18 organizations
| Organization | ACT 2026 Attendance |
|---|---|
Builds specialized AI agents for toxicology and regulatory work: in silico hazard prediction, PBPK modeling and drafting regulatory documents. | Session Sun Nov 15 8:00am–11:30am From Predictive Models to Collaborative Intelligence: The Role of Agentic AI in the Future of Toxicology (CE2)
Talk Sun Nov 15 8:00am–8:05am Talk Sun Nov 15 9:00am–9:30am Talk Mon Nov 16 9:50am–10:15am |
Schrödinger New York, NY | |
Computational chemistry software company that also develops its own drugs; presents physics-based genotoxicity screening and preclinical toxicity work. | Poster Mon Nov 16 5:00pm–6:30pm |
Certara Radnor, PA | |
Biosimulation software and services company; for nonclinical teams it offers SEND data tools such as SEND Explorer. | Booth Exhibiting at Booth 719 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm Session Mon Nov 16 9:00am–12:00pm The Role of Professional Judgment in Toxicology amidst the Rise of Artificial Intelligence and Computational Tools (S02)
Talk Mon Nov 16 9:25am–9:50am Talk Mon Nov 16 2:30pm–2:55pm Talk Tue Nov 17 8:00am–8:55am |
Instem Boston, MA | ◆Gold Supporter |
Software and services for preclinical study management, SEND data creation and review, and in silico safety prediction. | Booth Exhibiting at Booth 407 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm Talk Sun Nov 15 12:00pm–12:55pm |
MultiCASE Mayfield Heights, OH | |
Computational toxicology software and consulting for QSAR predictions, including ICH M7 assessments of drug impurities and REACH chemical evaluations. | Booth Exhibiting at Booth 410 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm Poster Mon Nov 16 5:00pm–6:30pm Talk Tue Nov 17 12:00pm–12:55pm |
ESQlabs Saterland, Germany | |
German modeling firm offering consulting, software and training in PBPK and systems pharmacology models, plus chemical risk assessment. | Poster Mon Nov 16 5:00pm–6:30pm Talk Tue Nov 17 10:45am–11:05am |
Sciome Research Triangle Park, NC | |
Research software and data science company building computational toxicology, QSAR and AI tools, including automated toxicity and property prediction. | Talk Sun Nov 15 2:00pm–2:30pm |
AxiomBio San Francisco, CA | |
Builds AI models that predict drug toxicity, including liver injury, from human cell data instead of animal studies. | Booth Exhibiting at Booth 110 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm |
Sable Bio London, UK | |
London software company whose Sable Target Intelligence platform assesses target-driven safety risk by integrating genetic, clinical, model and literature evidence. | Booth Exhibiting at Booth 612 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm |
Builds AI agent systems for pharma that connect a company's existing data to automate work such as regulatory documentation. | Talk Sun Nov 15 8:30am–9:00am |
AI drug-design company whose platform helps chemists generate and prioritize small molecules with better ADMET, PK and potency profiles. | Talk Sun Nov 15 10:30am–11:00am |
F FlashPath | |
Company presenting a data-driven analysis of which preclinical toxicity findings predict adverse events in people. | Poster Mon Nov 16 5:00pm–6:30pm |
AI drug-discovery company that embeds in drug programs, combining predictive models, lab robotics and chemists to design preclinical experiments. | Talk Mon Nov 16 11:15am–11:45am |
AI and machine learning firm offering life science data analysis, biomarker discovery and carcinogenicity risk assessment software and services. | Poster Mon Nov 16 5:00pm–6:30pm |
Instantly find 20 buyers from software and AI companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse ACT 2026 by
Organization type
Topic
- Nonclinical strategy and regulatory 58
- New approach methods 54
- Biologics and new modalities 43
- Chemical and environmental risk assessment 38
- Neurotoxicology 35
- Animal models and in vivo studies 35
- Bioanalysis, ADME and biomarkers 34
- In silico toxicology and AI 34
- Genetic toxicology and carcinogenicity 25
- Pathology 22
- Translational and clinical safety 22
- Safety pharmacology 21
- Immunotoxicology 21
- Developmental and reproductive toxicology 21
- Study data and software 12
- Inhalation toxicology 11
- Careers 5
Exhibit hall
Everyone
Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction